Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate.

What Was Tested

The paper reports a study of Methylene blue (non-peptide stack partner), published as a clinical trial.

The researchers aimed to assess the physiological influence of low grade exercise on the quality of skeletal scintigraphy using Tc-99m MDP.

Why It Was Studied

Tc-99m methylene diphosphonate [MDP] bone scan is the basis of the skeletal imaging in nuclear medicine being a highly sensitive tool for detecting bone diseases.

Who Took Part

According to the abstract, 92 volunteers were involved.

The age groups tagged for this paper are adults and middle-aged adults, both men and women.

Tc-99m MDP bone scan was done for 92 volunteers [Group 1; G1].

Five days later, the same subjects were re-scanned [Group 2; G2] after an exercise on treadmill for 5 minutes.

How the Study Was Run

Image quality was assessed using quantitative measures whereby equal regions of interest (ROI) were drawn over the femoral diaphysis, and the contralateral adductor area.

The total number of counts from the bone [B] ROI and soft tissue [ST] ROI was expressed as a ratio [B:ST ratio] and a mean value for each was established.

What Was Measured

Topics PubMed links to this paper include Bone and Bones, Exercise, Radionuclide Imaging and Technetium Tc 99m Medronate.

What This Means in Plain Language

This is a clinical trial of Methylene blue (non-peptide stack partner) in 92 volunteers.

Results are reported in around 2 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2015 (Nuclear medicine review. Central & Eastern Europe), a journal based in Poland.

More context: the Methylene blue (non-peptide stack partner) compound page, all human trials.